About
MPN Research Foundation

Partner. Advocate. Friend. At the MPN Research Foundation, we’re committed to standing with you in the fight against polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF) – the group of blood cancers collectively known as myeloproliferative neoplasms.

About Us

Providing education and resources for a better today. Investing in research for a better tomorrow.

MPNRF By the Numbers

  • $MM
    • MPN Research Funded
    • Researchers Supported
    • Projects Funded

Recent News

How does MDM2 inhibition work to treat MPNs?

MPN News | 7/9/19

Renowned experts Dr. Srdan Verstovsek and Dr. Jason Gotlib discuss MDM2 inhibition as an avenue for the treatment of MPNs and share information on an upcoming MDM2 clinical trial.

Read More

Promedior Presents Positive Data from a Phase 2 Study of PRM-151 in MF patients

MPN News | 6/17/19

Positive safety and early efficacy clinical data was proven during Promedior's Phase 2 study of PRM-151 in MF patients

Read More

Imago BioSciences to Expand Clinical Trial of IMG-7829 for MF Patients

MPN News | 6/17/19

"IMG-7289 has shown tremendous promise to be a meaningful treatment option for myelofibrosis patients, and these data support our clinical program," said Hugh Young Rienhoff, CEO of Imago BioSciences

Read More
More News

What is Primary Myleofibrosis (MF)?

Primary Myleofibrosis (MF)

PMF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.

Learn about PMF

What is Essential Thrombocythemia (ET)?

Essential Thrombocythemia (ET)

Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.

Learn about ET

What is Polycythemia Vera (PV)?

Polycythemia Vera (PV)

The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.

Learn about PV

Patient Stories

See All Patient Stories

Diane Hilton Essential Thromobocythemia (ET)

Meet MPN patient Diane Hilton and read about her 31-year journey with Interferon.

Meet Diane Hilton

Ryan Tellini's Journey with Interferon Myelofibrosis (MF)

Learn about MF patient Ryan Tellini and his journey with Interferon.

Meet Ryan Tellini's Journey with Interferon

Linda Reekie Polycythemia Vera (PV)

Meet PV patient, Linda Reekie from Port St. Lucie, FL

Meet Linda Reekie

Nancy Francis Essential Thromobocythemia (ET)

Meet ET patient, Nancy Francis from Gander Bay, Newfoundland

Meet Nancy Francis

Jessica Harshbarger Essential Thromobocythemia (ET)

Meet ET patient, Jessica Harshbarger from Chicago, IL

Age: 42 Meet Jessica Harshbarger

Jen Hawkins Essential Thromobocythemia (ET)

Meet ET patient, Jen Hawkins from Tri-Cities, Washington

Age: 31 Meet Jen Hawkins

With an orphan disease, the support can be hard to find. I found that support at the MPN Research Foundation.

Juan Alderete, PV 06

Ready to do more?

Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.

Get Involved Now.

Stay Connected

With your generous gift, you can change a MPN patient's prognosis.

By supporting MPN Research Foundation, you're also supporting countless doctors and researchers around the world who are working to find a cure for these rare diseases.

Donate Now

Join Cancer Connect

A safe space to chat with others living with PV, ET and MF

Start here!

MPN Community Calendar

HIKEMF
Sat, May 21st, 10am

Attend the Event

MPN Information kit

Be the first to know about what's going on in the PV, ET, and MF community.

Get the Kit